In the absence of their own translational machinery, all viruses must gain access to host cell ribosomes to synthesize viral proteins and replicate. Ribosome recruitment and scanning of capped host mRNAs is facilitated by the multisubunit eIF (eukaryotic initiation factor) 4F, which consists of a cap-binding protein, eIF4E and an RNA helicase, eIF4A, assembled on a large scaffolding protein, eIF4G. Although inactivated by many viruses to inhibit host translation, a growing number of DNA viruses are being found to employ diverse strategies to stimulate eIF4F activity in infected cells and maximize viral protein synthesis. These strategies include stimulation of cellular mTOR (mammalian target of rapamycin) signalling to inactivate 4E-BPs (eIF4E-binding proteins), a family of translational repressors that limit eIF4E availability and eIF4F complex formation, together with modulating the activity of the eIF4E kinase Mnk (mitogen-activated protein kinase signal-integrating kinase) in a variety of manners to regulate both host and viral mRNA translation. In some cases, specific viral proteins that mediate these signalling events have been identified, whereas others have been shown to interact with host translation initiation factors or complexes and modify their activity and/or subcellular localization. The present review outlines current understanding of the role of eIF4F in the life cycle of various DNA viruses and discusses its potential as a therapeutic target to suppress viral infection.
The eIF (eukaryotic translation initiation factor) 4F complex and translation initiation
Eukaryotic mRNAs are capped at their 5 -end by a 7-methyl-GTP and polyadenylated at their 3 -end, both of which function during translation initiation. Ribosome recruitment to the 5 -end is facilitated by eIF4F, which consists of a small cap-binding protein, eIF4E, an ATP-dependent RNA helicase, eIF4A, and a large scaffold protein, eIF4G ( Figure 1 ) [1] . eIF4G also binds PABP [poly(A)-binding protein], an interaction that mediates 5 →3 -end communication thought to act as a quality-control mechanism to promote efficient translation of intact correctly processed mRNAs. In addition, eIF4G interacts with the multisubunit complex eIF3, bridging the small (40S) ribosomal subunit to the eIF4F complex. Once assembled on the cap, the helicase activity of the eIF4F complex unwinds secondary structure in the 5 -UTR (untranslated region) to facilitate ribosomal Key words: eukaryotic translation initiation factor 4F (eIF4F), mammalian target of rapamycin (mTOR), mitogen-activated protein kinase signal-integrating kinase (Mnk), translation initiation, viral infection. Abbreviations used: ASFV, African swine fever virus; dsDNA, double-stranded DNA; E4-ORF,
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The availability of the cap-binding subunit of eIF4F is regulated by a family of small 4E-BPs (eIF4E-binding proteins) [1] . In their hypophosphorylated state, 4E-BPs bind to the same site on eIF4E as eIF4G, thereby acting as competitive inhibitors of eIF4F complex formation ( Figure 1 ). In response to a variety of environmental cues to stimulate translation, signalling through pathways such as PI3K (phosphoinositide 3-kinase)-Akt-TSC (tuberous sclerosis complex)/PRAS40 (proline-rich Akt substrate of 40 kDa) mediates activation of mTOR (mammalian target of rapamycin), a kinase that phosphorylates both eIF4G and 4E-BP. Phosphorylation of 4E-BP occurs on multiple sites and causes it to release eIF4E, making the cap-binding subunit available for eIF4F complex formation. Once present in an eIF4F complex, eIF4E is phosphorylated by the eIF4G-associated Mnk [MAPK (mitogen-activated protein kinase) signal-integrating kinase], which acts as a convergence point for two important mitogenic signalling pathways, ERK (extracellular-signal-regulated kinase) and p38 MAPK. However, the exact function of eIF4E phosphorylation remains unclear, correlating both positively and negatively with translation rates under different circumstances.
Mammalian viruses have evolved an array of strategies that target eIF4F to influence both viral and host mRNA translation. Many RNA viruses inactivate eIF4F to inhibit (red) acts as a scaffold for the assembly of eIF4F by binding the cap-binding protein, eIF4E (green) and the helicase eIF4A (turquoise). eIF4G also binds PABP (brown), which circularizes mRNAs, Mnk (purple), which phosphorylates eIF4E, as well as eIF3 (blue), which bridges the small 40 S ribosomal subunit to eIF4G. mTOR mediates eIF4G and 4E-BP phosphorylation, whereas ERK and p38 MAPK activate Mnk. Circled P's represent phosphorylation events.
host protein synthesis, initiating translation of their own mRNAs by cap-independent processes that include the use of IRESs (internal ribosome entry sites) [2] . However, the variety of both inhibitory and stimulatory approaches employed by DNA viruses to manipulate eIF4F and the viral factors involved (outlined in Figure 2 ) are just beginning to emerge.
Adenoviruses
Adenoviruses were named after the adenoid tissue in which they were first discovered and cause acute respiratory infections, as well as conjunctivitis and infantile gastroenteritis. Their non-enveloped virions contain a linear 26-45 kb dsDNA (double-stranded DNA) genome that is replicated in the nucleus, whereas transcripts are capped and polyadenylated.
Early in infection, only low levels of viral proteins are produced, whereas total protein synthesis is increased coincident with 4E-BP inactivation [3, 4] . 4E-BP1 phosphorylation has been shown to involve adenovirus E4-ORF (E4 region containing open reading frame) 1-mediated activation of PI3K and PP2A (protein phosphatase 2A)-dependent E4-ORF4-mediated activation of mTOR [5] . At later stages of infection, host translation is inhibited, despite continued phosphorylation of 4E-BPs. This inhibition correlates with desphosphorylation of eIF4E [6, 7] , which is caused by the displacement of Mnk from the eIF4F complex by the binding of adenovirus 100 k protein to the C-terminus of eIF4G [8, 9] . In contrast, selective translation of late viral mRNAs under these conditions is mediated by a common 200 nt sequence in their 5 -UTR, termed the tripartite leader, which complements 18 S rRNA and binds eIF4G-associated 100 k, promoting initiation by a ribosome translocation process called 'shunting', which is distinct from conventional scanning [10] [11] [12] [13] [14] [15] .
Papillomaviruses and polyomaviruses
These small non-enveloped viruses contain a circular 5-8 kb dsDNA genome and are associated with a variety of cancers. HPVs (human papillomaviruses) induce benign lesions such as warts as well as uterine and urogenital malignancies. Although little is known about their effects on eIF4F, there is evidence that HPV deregulates 4E-BP1, which may contribute to cellular transformation [16] . Notably, polycistronic HPV mRNAs utilize both scanning and shunting mechanisms to translate distinct reading frames [17] .
Deriving their name from the Greek for 'multiple tumour virus', polyomaviruses include SV40 (simian virus 40), BK virus and JC virus. Early in SV40 infection, host translation is unaffected and the mTOR substrates 4E-BP1 and eIF4G are phosphorylated. As infection progresses, however, the accumulation of small T-antigen causes a PP2A-dependent dephosphorylation of 4E-BP1, leading to disruption of eIF4F and attenuation of host protein synthesis [18] . The possibility that late SV40 mRNAs employ cap-independent mechanisms of translation under such conditions is supported by the demonstration of IRES activity in SV40 polycistronic 19 S late mRNAs [19] .
Herpesviruses
Herpesviruses are widely disseminated in nature, eight of which infect humans. They exist in both productive (lytic) and non-productive (latent) states, allowing them to establish lifelong infections of their host. Herpesviruses are enveloped and have a linear 124-230 kb dsDNA genome that is replicated in the nucleus, whereas their mRNAs are capped and polyadenylated. They are broadly divided into three subfamilies, the α-, β-and γ -herpesviruses.
HSV-1 (herpes simplex virus type 1)
HSV-1 is an α-herpesvirus that causes cold sores, corneal blindness and encephalitis. The replicative cycle is short and causes a robust inhibition of host protein synthesis mediated by the suppression of host transcription and mRNA processing/export, as well as the activity of VHS (virion host shut-off), a viral endonuclease that associates with eIF4A and eIF4H [20] . In addition to degrading host mRNAs, VHS is thought to play a role in regulating the temporal pattern of viral mRNA expression.
Until recently, whether inactivation of eIF4F also contributes to host shut-off during HSV-1 infection remained unknown. When examined, however, HSV-1 was found to stimulate eIF4E phosphorylation and eIF4F complex formation in resting primary human cells [21] . eIF4E phosphorylation is mediated by p38 MAPK activation [21] , which is induced by the HSV-1 protein ICP (infected cell protein) 27 [22, 23] , whereas ERK is inactivated. Inhibitors of p38 MAPK or Mnk prevent eIF4E phosphorylation and reduce both the rates of protein synthesis and the spread of virus in cultures infected with small amounts of HSV-1, but have little impact when large input doses of virus are used [21] . As such, the eIF4E kinase Mnk plays a subtle, but biologically important, role in stimulating viral protein synthesis.
HSV-1 infection also activates mTOR signalling, resulting in phosphorylation and degradation of 4E-BP1 [21] . 4E-BP1 degradation is suppressed by the mTOR inhibitor rapamycin or the proteasome inhibitor MG132, suggesting that 4E-BP1 is degraded in infected cells by the proteasome subsequent to its release from eIF4E. Whether specific viral functions regulate 4E-BP1 phosphorylation and target it for degradation remains unknown.
The HSV-1 protein ICP6 has been shown to associate with eIF4G and enhance the eIF4E-eIF4G interaction in vitro [24] . The N-terminal domain of ICP6 is homologous with the cellular chaperone Hsp27 (heat-shock protein 27), which regulates eIF4F levels during stress responses [25] . Viruses lacking ICP6 fail to increase eIF4F levels despite inactivating 4E-BP1, suggesting that multiple processes are involved in fostering eIF4F complex formation in infected cells. In addition, VHS associates with eIF4A/eIF4H and, despite its endonuclease activity, has been shown to enhance translation from IRES elements and sequences within HSV-1 5 -UTRs [26] .
Despite polyadenylation of their mRNAs and enhanced eIF4F complex formation, the association of PABP with eIF4F is not enhanced by HSV-1 in primary cells and is decreased in HeLa cells [27, 28] . Indeed, PABP is redistributed to the nucleus during infection [28, 29] , which may play a role in nuclear processing and/or shuttling of viral mRNAs and could potentially contribute to shut-off of host translation. The multifunctional HSV-1 protein ICP27 associates with PABP [30] , although suggestions that this contributes to the nuclear redistribution of PABP have been disputed [28, 29] . However, when tethered to a reporter RNA, ICP27 can stimulate translation [31] . In infected cells, ICP27 is required for efficient synthesis of specific subsets of viral proteins [32, 33] . As such, ICP27, in part through its association with PABP and induction of p38 MAPK, has a complex multifunctional role in regulating the processing, transport and translation of viral transcripts.
HCMV (human cytomegalovirus)
HCMV is a β-herpesvirus that causes serious illness in the immunocompromised and is the leading cause of virusassociated birth defect in newborns. HCMV has a protracted life cycle and does not dramatically alter host protein synthesis.
HCMV activates mTOR signalling and phosphorylates both 4E-BP1 and eIF4G in a manner that is largely insensitive to rapamycin [27, 34] . Infection modifies the substrate specificities of distinct raptor (regulatory associated protein of mTOR)-and rictor (rapamycin-insensitive companion of mTOR)-containing mTORCs (mTOR complexes), termed mTORC1 and mTORC2 respectively [35] . In addition, the HCMV protein UL38 associates with TSC2, a component of the TSC, and prevents it from inhibiting mTORC1 [36] . Torin1, a specific inhibitor of mTORC1 and mTORC2, blocks 4E-BP phosphorylation and disrupts eIF4F, suppressing virus replication and demonstrating the importance of rapamycin-insensitive mTOR signalling during HCMV infection [37] .
As HCMV infection progresses, the abundance of core eIF4F components and PABP is greatly increased, as are the levels of eIF4F complexes [27] . PAA (phosphonoacetic acid), which inhibits viral DNA synthesis and progression to late stages of infection, reduces the accumulation of initiation factors and levels of eIF4F. As such, increased intracellular concentrations of initiation factors may play an important part in driving eIF4F formation during infection. In addition, HCMV UL69, homologous with HSV-1 ICP27, associates with eIF4A and PABP and excludes 4E-BP1 from cap complexes, although the mechanism by which this exclusion occurs is unknown [38] .
By activating p38 MAPK and ERK signalling pathways, HCMV also stimulates eIF4E phosphorylation [27] . A combination of p38 MAPK and ERK inhibitors or the Mnk inhibitor CGP57380 reduces the spread of HCMV in cultures, demonstrating the importance of Mnk and eIF4E phosphorylation in the replicative cycle of another herpesvirus.
KSHV (Kaposi's sarcoma-associated herpesvirus) and EBV (Epstein-Barr virus)
KSHV and EBV are lymphotropic γ -herpesviruses associated with a variety of disease states, including cancer. KSHV enhances eIF4F complex formation as well as p38 MAPK-and ERK-mediated eIF4E phosphorylation during reactivation from latency in B-cell lines [39] . The Mnk inhibitor CGP57380 suppresses virus reactivation, demonstrating that Mnk and eIF4E phosphorylation also play an important role in the reactivation phase of the herpesvirus lifecycle. Similar to HSV-1 lytic infection, KSHV reactivation suppresses host translation, does not stimulate the recruitment of PABP to eIF4F complexes and results in a redistribution of PABP to the nucleus [39] . Two KSHV proteins, K10/10.1 and SOX, have been shown to interact with PABP, with the latter causing nuclear redistribution of PABP and inducing cellular mRNA destruction through aberrant polyadenylation [40, 41] .
Both KSHV reactivation and EBV infection induce 4E-BP1 phosphorylation [39, 42] . The vGPCR (viral G-proteincoupled receptor) of KSHV [43] and the latency protein LMP2A (latent membrane protein 2A) of EBV [42] have been reported to stimulate mTOR, which may also contribute to cellular transformation by these viruses.
Poxviruses
Poxviruses are large enveloped viruses that contain a linear 130-300 kb dsDNA genome. They include VARV (variola virus), the causative agent of smallpox, and VACV (vaccinia virus), a poxvirus closely related to VARV that was used as a vaccine against smallpox. A striking feature of poxvirus replication is that it occurs exclusively in the cytoplasm within compartments called viral factories.
Early studies focused largely on the fact that VACV did not negatively affect eIF4F function, in contrast with many other viruses being studied at that time [44, 45] . Indeed, poxvirus mRNAs were found to be translated in a cap-dependent manner albeit with a reduced dependence upon initiation factors compared with host mRNAs [46] [47] [48] [49] . Recent work, however, has demonstrated that VACV increases eIF4F complex levels in normal human cells and enhances PABP binding [50] . Both p38 MAPK and ERK are activated during infection and stimulate eIF4E phosphorylation. The Mnk inhibitor CGP57380 suppresses poxvirus replication and spread during infection with small amounts of virus, an effect that has been genetically confirmed in Mnk-deficient mouse embryo fibroblasts [50] .
VACV inactivates 4E-BP1, phosphorylating and targeting it to the proteasome in a rapamycin-sensitive manner similar to HSV-1 [50] . VACV stimulates mTOR by activating PI3K signalling, and the PI3K inhibitor LY294002 causes a dramatic accumulation of hypophosphorylated 4E-BP1, disruption of eIF4F and a significant decrease in viral protein synthesis and replication [51] . The fact that rapamycin does not induce the same effects suggests that rapamycin-insensitive mTOR, or another LY294002-sensitive function, is the dominant regulator of eIF4F formation in VACV-infected cells.
VACV infection also has a dramatic effect on the localization of initiation factors within the host cell [50, 52] . Specifically, eIF4E and eIF4G are redistributed to discrete regions within viral factories. Notably, although small amounts of PABP are also evident within factories, a large portion of the cellular pool of PABP remains on the periphery of these structures. The composition of host factors within viral factories appears to be selective, as the localization of a number of other RNA-binding proteins remains unaltered. Whether this is a passive process or mediated by a specific viral factor(s) remains to be determined.
Asfarvirus
ASFV (African swine fever virus) is the sole member of the Asfarviridae. Similar to poxviruses, ASFV replicates in the cytoplasm of infected cells and has been shown to redistribute translation initiation factors (eIF4E, eIF4G, eIF2α and eIF3b), elongation factors (eEF2) and ribosomal P protein to regions within and around viral replication compartments [53] . Infection is also accompanied by rapamycin-sensitive phosphorylation of 4E-BP1, increased levels of eIF4F and enhanced phosphorylation of eIF4E. Both rapamycin and the Mnk inhibitor CGP57380 as well as siRNAs (short interfering RNAs) targeting eIF4E reduce ASFV replication, underpinning the importance of eIF4F in the ASFV life cycle [53] .
Therapeutic targeting of eIF4F
Suppressing eIF4F activity has gained recognition in the field of cancer therapeutics because efficient translation of structurally complex mRNAs encoding growth-related and anti-apoptotic proteins has a high requirement for eIF4F, in contrast with the low requirement of structurally simpler housekeeping mRNAs, offering a potentially safe and selective means to target tumours. Whereas small DNA viruses (adenovirus/polyomavirus) inactivate eIF4F as infection progresses, a growing number of larger DNA viruses are being found to stimulate eIF4F activity. Inhibition of Mnk suppresses herpesvirus, poxvirus and asfarvirus replication, albeit modestly [21, 27, 50, 53] . The mTORC1/mTORC2 inhibitor Torin1 disrupts eIF4F and significantly reduces the replication of representative α-, β-and γ -herpesviruses [37] , whereas siRNAs targeting eIF4F components suppress asfarvirus and poxvirus protein synthesis [53, 54] . Although not absolutely essential for viral protein synthesis, perhaps due to residual eIF4F in experimental systems or a low requirement of viral mRNAs for its activity akin to cellular housekeeping mRNAs, targeting eIF4F may offer an effective broad-spectrum approach to suppressing infection by a number of medically important DNA viruses. In addition, as a central factor in both DNA virus replication and cellular transformation, targeting eIF4F might be an effective approach to treating virus-induced tumours. 
